Vanda Pharmaceuticals (VNDA) Current Taxes (2010 - 2011)
Vanda Pharmaceuticals recorded quarterly Current Taxes of $2.1 million in Q3 2011, down 5.09% quarter-over-quarter from $2.2 million in Q2 2011.
Vanda Pharmaceuticals' Current Taxes history runs 2 years deep, the most recent figure standing at $2.1 million for Q3 2011.
- In Q3 2011, Current Taxes changed N/A year-over-year to $2.1 million; the TTM figure through Sep 2011 stood at $2.1 million (changed N/A YoY), while the FY2010 annual figure was $2.3 million, changed N/A from the prior year.
- Current Taxes came in at $2.1 million for Q3 2011 at Vanda Pharmaceuticals, down from $2.2 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $2.3 million in Q4 2010 to a low of $2.1 million in Q3 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 2.11 Mn |
| Jun 30, 2011 | 2.22 Mn |
| Dec 31, 2010 | 2.27 Mn |